Early age-related macular degeneration, cognitive function, and dementia: The cardiovascular health study

Archives of Ophthalmology

Volumn 127, Issue 5, 2009, Pages 667-673

  Baker, Michelle L ^a   Wang, Jie Jin ^a,b   Rogers, Sophie ^a   Klein, Ronald ^c   Kuller, Lewis H ^d   Larsen, Emily K ^e   Wong, Tien Yin ^a,f  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b UNIVERSITY OF SYDNEY   (Australia)

^c UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^d UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

^e UNIVERSITY OF WASHINGTON   (United States)

^f NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN E;

AGED; ALZHEIMER DISEASE; ARTICLE; CHOLESTEROL BLOOD LEVEL; CIGARETTE SMOKING; CLINICAL ASSESSMENT; COGNITION; CONFIDENCE INTERVAL; CONTROLLED STUDY; DEMENTIA; DIABETES MELLITUS; DISEASE ASSOCIATION; EYE PHOTOGRAPHY; FEMALE; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; MINI MENTAL STATE EXAMINATION; NEUROPSYCHOLOGICAL TEST; PRIORITY JOURNAL; RETINA MACULA AGE RELATED DEGENERATION; RISK FACTOR; SYSTOLIC BLOOD PRESSURE; UNITED STATES; CARDIOVASCULAR DISEASE; COGNITIVE DEFECT; INTELLIGENCE TEST; PROSPECTIVE STUDY; RETINA MACULA DEGENERATION; RISK;

AGED; AGED, 80 AND OVER; CARDIOVASCULAR DISEASES; COGNITION DISORDERS; DEMENTIA; FEMALE; HUMANS; INTELLIGENCE TESTS; MACULAR DEGENERATION; MALE; NEUROPSYCHOLOGICAL TESTS; ODDS RATIO; PROSPECTIVE STUDIES; RISK FACTORS; UNITED STATES;

EID: 65649144141     PISSN: 00039950     EISSN: 15383601     Source Type: Journal    
DOI: 10.1001/archophthalmol.2009.30     Document Type: Article

References (51)

1. Tielsch JM, Javitt JC, Coleman A, Katz J, Sommer A. The prevalence of blindness and visual impairment among nursing home residents in Baltimore. N Engl J Med. 1995;332(18):1205-1209.
2. Mitchell P, Smith W, Attebo K, Wang JJ. Prevalence of age-related maculopathy in Australia: the Blue Mountains Eye Study. Ophthalmology. 1995;102(10):1450-1460.
3. Klaver CC, Wolfs RC, Vingerling JR, Hofman A, de Jong PT. Age-specific prevalence and causes of blindness and visual impairment in an older population: the Rotterdam Study. Arch Ophthalmol. 1998;116(5):653-658. (Pubitemid 28414581)
4. Dentchev T, Milam AH, Lee VM, Trojanowski JQ, Dunaief JL. Amyloid-β is found in drusen from some age-related macular degeneration retinas, but not in drusen from normal retinas. Mol Vis. 2003;9:184-190. (Pubitemid 38097585)
5. Curcio CA, Millican CL, Allen KA, Kalina RE. Aging of the human photoreceptor mosaic: evidence for selective vulnerability of rods in central retina. Invest Ophthalmol Vis Sci. 1993;34(12):3278-3296. (Pubitemid 23346660)
6. Green WR, Enger C. Age-related macular degeneration histopathologic studies: the 1992 Lorenz E. Zimmerman Lecture. Ophthalmology. 1993;100(10):1519-1535.
7. Sarks SH, Arnold JJ, Killingsworth MC, Sarks JP. Early drusen formation in the normal and aging eye and their relation to age related maculopathy: a clinicopathological study. Br J Ophthalmol. 1999;83(3):358-368. (Pubitemid 29112419)
8. Mrak RE, Griffin ST, Graham DI. Aging-associated changes in human brain. J Neuropathol Exp Neurol. 1997;56(12):1269-1275. (Pubitemid 28006572)
9. Hinton DR, Sadun AA, Blanks JC, Miller CA. Optic-nerve degeneration in Alzheimer's disease. N Engl J Med. 1986;315(8):485-487. (Pubitemid 16034149)
10. Blanks JC, Torigoe Y, Hinton DR, Blanks RH. Retinal pathology in Alzheimer's disease, I: ganglion cell loss in foveal/parafoveal retina. Neurobiol Aging. 1996;17(3):377-384.
11. Blanks JC, Schmidt SY, Torigoe Y, Porrello KV, Hinton DR, Blanks RH. Retinal pathology in Alzheimer's disease, II: regional neuron loss and glial changes in GCL. Neurobiol Aging. 1996;17(3):385-395. (Pubitemid 26200415)
12. Giannakopoulos P, Hof PR, Michel JP, Guimon J, Bouras C. Cerebral cortex pathology in aging and Alzheimer's disease: a quantitative survey of large hospital-based geriatric and psychiatric cohorts. Brain Res Rev. 1997;25(2):217-245. (Pubitemid 27501801)
13. Vingerling JR, Klaver CC, Hofman A, de Jong PT. Epidemiology of age-related maculopathy. Epidemiol Rev. 1995;17(2):347-360. (Pubitemid 26096879)
14. Klein R, Klein BE, Linton KL, DeMets DL. The Beaver Dam Eye Study: the relation of age-related maculopathy to smoking. Am J Epidemiol. 1993;137(2): 190-200. (Pubitemid 23083671)
15. Klein R, Klein BE, Franke T. The relationship of cardiovascular disease and its risk factors to age-related maculopathy: the Beaver Dam Eye Study. Ophthalmology. 1993;100(3):406-414. (Pubitemid 23088542)
16. Klein R, Klein BE, Jensen SC. The relation of cardiovascular disease and its risk factors to the 5-year incidence of age-related maculopathy: the Beaver Dam Eye Study. Ophthalmology. 1997;104(11):1804-1812. (Pubitemid 28100335)
17. Ott A, Slooter AJC, Hofman A, et al. Smoking and risk of dementia and Alzheimer's disease in a population-based cohort study: the Rotterdam Study. Lancet. 1998;351(9119):1840-1843. (Pubitemid 28279707)
18. Skoog I, Lernfelt B, Landahl S, et al. 15-year longitudinal study of blood pressure and dementia. Lancet. 1996;347(9009):1141-1145. (Pubitemid 126512042)
19. Anstey KJ, von Sanden C, Salim A, O'Kearney R. Smoking as a risk factor for dementia and cognitive decline: a meta-analysis of prospective studies. Am J Epidemiol. 2007;166(4):367-378. (Pubitemid 47216800)
20. Snowdon DA, Greiner LH, Mortimer JA, Riley KP, Greiner PA, Markesbery WR. Brain infarction and the clinical expression of Alzheimer disease: the Nun Study. JAMA. 1997;277(10):813-817. (Pubitemid 27111317)
21. Wong TY, Klein R, Sun C, et al; Atherosclerosis Risk in Communities Study. Age-related macular degeneration and risk for stroke. Ann Intern Med. 2006; 145(2):98-106.
22. Evans DA, Beckett LA, Field TS, et al. Apolipoprotein E ε4 and incidence of Alzheimer disease in a community population of older persons. JAMA. 1997;277(10):822-824. (Pubitemid 27111319)
23. Souied EH, Benlian P, Amouyel P, et al. The ε4 allele of the apolipoprotein E gene as a potential protective factor for exudative age-related macular degeneration. Am J Ophthalmol. 1998;125(3):353-359. (Pubitemid 28124364)
24. Klaver CC, Kliffen M, van Duijn CM, et al. Genetic association of apolipoprotein E with age-related macular degeneration. Am J Hum Genet. 1998;63(1):200-206. (Pubitemid 30428336)
25. Wong TY, Klein R, Nieto FJ, et al. Is early age-related maculopathy related to cognitive function? the Atherosclerosis Risk in Communities Study. Am J Ophthalmol. 2002;134(6):828-835. (Pubitemid 35425450)
26. Pham TQ, Kifley A, Mitchell P, Wang JJ. Relation of age-related macular degeneration and cognitive impairment in an older population. Gerontology. 2006;52(6):353-358. (Pubitemid 44670157)
27. Klaver CC, Ott A, Hofman A, Assink JJ, Breteler MM, de Jong PT. Is age-related maculopathy associated with Alzheimer's disease? the Rotterdam Study. Am J Epidemiol. 1999;150(9):963-968. (Pubitemid 29508649)
28. Tell GS, Fried LP, Hermanson B, Manolio TA, Newman AB, Borhani NO. Recruitment of adults 65 years and older as participants in the Cardiovascular Health Study. Ann Epidemiol. 1993;3(4):358-366. (Pubitemid 23195820)
29. Fried LP, Borhani NO, Enright P, et al. The Cardiovascular Health Study: design and rationale. Ann Epidemiol. 1991;1(3):263-276.
30. Wong TY, Klein R, Sharrett AR, et al. The prevalence and risk factors of retinal microvascular abnormalities in older persons: the Cardiovascular Health Study. Ophthalmology. 2003;110(4):658-666. (Pubitemid 36520060)
31. Wong TY, Hubbard LD, Klein R, et al. Retinal microvascular abnormalities and blood pressure in older people: the Cardiovascular Health Study. Br J Ophthalmol. 2002;86(9):1007-1013.
32. Klein R, Davis MD, Magli YL, Segal P, Klein BE, Hubbard L. The Wisconsin age-related maculopathy grading system. Ophthalmology. 1991;98(7):1128-1134.
33. Kuller LH, Shemanski L, Manolio T, et al. Relationship between ApoE, MRI findings, and cognitive function in the Cardiovascular Health Study. Stroke. 1998;29(2):388-398. (Pubitemid 28086681)
34. Lopez OL, Kuller LH, Fitzpatrick A, Ives D, Becker JT, Beauchamp N. Evaluation of dementia in the Cardiovascular Health Cognition Study. Neuroepidemiology. 2003;22(1):1-12. (Pubitemid 36131968)
35. Baker ML, Marino Larsen EK, Kuller LH, et al. Retinal microvascular signs, cognitive function, and dementia in older persons: the Cardiovascular Health Study. Stroke. 2007;38(7):2041-2047. (Pubitemid 47012265)
36. Wechsler D. WAIS-R Manual. Cleveland, OH: Psychological Corp; 1981.
37. Teng EL, Chui HC. The Modified Mini-Mental State (3MS) examination. J Clin Psychiatry. 1987;48(8):314-318. (Pubitemid 17138128)
38. Salthouse TA. The role of memory in the age decline in digit-symbol substitution performance. J Gerontol. 1978;33(2):232-238. (Pubitemid 8290877)
39. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 4th ed. Washington, DC: American Psychiatric Association; 1994.
40. Chui HC, Victoroff JI, Margolin D, Jagust W, Shankle R, Katzman R. Criteria for the diagnosis of ischemic vascular dementia proposed by the State of California Alzheimer's Disease Diagnostic and Treatment Centers. Neurology. 1992;42(3, pt 1):473-480.
41. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology. 1984;34(7):939-944. (Pubitemid 14076461)
42. Haan MN, Shemanski L, Jagust WJ, Manolio TA, Kuller L. The role of APOE ε4 in modulating effects of other risk factors for cognitive decline in elderly persons. JAMA. 1999;282(1):40-46. (Pubitemid 29318931)
43. Hixson JE, Vernier DT. Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with Hha I. J Lipid Res. 1990;31(3):545-548. (Pubitemid 20107994)
44. Tikellis G, Sun C, Gorin MB, et al. Apolipoprotein E gene and age-related maculopathy in older individuals: the Cardiovascular Health Study. Arch Ophthalmol. 2007;125(1):68-73. (Pubitemid 46072378)
45. Ives DG, Fitzpatrick AL, Bild DE, et al. Surveillance and ascertainment of cardiovascular events: the Cardiovascular Health Study. Ann Epidemiol. 1995;5(4):278-285.
46. Furberg CD, Manolio TA, Psaty BM, et al; Cardiovascular Health Study Collaborative Research Group. Major electrocardiographic abnormalities in persons aged 65 years and older: the Cardiovascular Health Study. Am J Cardiol. 1992;69(16):1329-1335.
47. Robbins J, Wahl P, Savage P, Enright P, Powe N, Lyles M. Hematological and biochemical laboratory values in older Cardiovascular Health Study participants. J Am Geriatr Soc. 1995;43(8):855-859.
48. Russell EW. WAIS factor analysis with brain-damaged subjects using criterion measures. J Consult Clin Psychol. 1972;39(1):133-139.
49. Wechsler D. The Measurement and Appraisal of Adult Intelligence. Baltimore, MD: Williams & Williams; 1958.
50. Klein R, Klein BE, Marino EK, et al. Early age-related maculopathy in the Cardiovascular Health Study. Ophthalmology. 2003;110(1):25-33. (Pubitemid 36068722)
51. Kuller LH, Lopez OL, Newman A, et al. Risk factors for dementia in the Cardiovascular Health Cognition study. Neuroepidemiology. 2003;22(1):13-22. (Pubitemid 36131969)